Zobrazeno 1 - 10
of 494
pro vyhledávání: '"Hiromi, Kumon"'
Publikováno v:
BMC Research Notes, Vol 15, Iss 1, Pp 1-8 (2022)
Abstract Objective The detection and monitoring of DNA methylation status in circulating tumor cell DNA (ctDNA) provides critical insights into cancer diagnosis and progression. The methylation status of the Dickkopf-related protein 3 (DKK3) promoter
Externí odkaz:
https://doaj.org/article/cb696a0d271440079a650fda97afdd26
Autor:
Ai Miyamoto, Tomoko Honjo, Mirei Masui, Rie Kinoshita, Hiromi Kumon, Kazuhiro Kakimi, Junichiro Futami
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Serum autoantibody to cancer/testis antigens (CTAs) is a critical biomarker that reflects the antitumor immune response. Quantitative and multiplexed anti-CTA detection arrays can assess the immune status in tumors and monitor therapy-induced antitum
Externí odkaz:
https://doaj.org/article/bcaf913dd4dd48b0abec09758607b6c5
Autor:
Yasuhiko Hattori, Kazuhiko Kurozumi, Yoshihiro Otani, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Kentaro Fujii, Yusuke Tomita, Tetsuo Oka, Yuji Matsumoto, Yosuke Shimazu, Hiroyuki Michiue, Hiromi Kumon, Isao Date
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273242 (2022)
Reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) is a tumor suppressor and its overexpression has been shown to exert anti-tumor effects as a therapeutic target gene in many human cancers. Recently, we demonstrated the anti-glioma eff
Externí odkaz:
https://doaj.org/article/60c3b1065683424a95b1b96535ea3c5a
Autor:
Hidewaki Nakagawa, Yusuke Nakamura, Taro Shuin, Tomoaki Fujioka, Tsuneharu Miki, Yoichi Mizutani, Hideyuki Akaza, Toru Shimazui, Masayoshi Yokoyama, Nozomu Tanji, Kenjiro Kohri, Keiichi Tozawa, Mikio Namiki, Hiroyuki Konaka, Hiromi Kumon, Yasutomo Nasu, Yataro Daigo, Hiroki Yoshioka, Wataru Obara, Ryo Takata, Shingo Ashida, Tatsuhiko Tsunoda, Mutsuo Furihata, Kenji Tamura
Supplementary Table 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1306a606a2873717aca85161a54d6f4a
https://doi.org/10.1158/0008-5472.22368555.v1
https://doi.org/10.1158/0008-5472.22368555.v1
Autor:
Hidewaki Nakagawa, Yusuke Nakamura, Taro Shuin, Tomoaki Fujioka, Tsuneharu Miki, Yoichi Mizutani, Hideyuki Akaza, Toru Shimazui, Masayoshi Yokoyama, Nozomu Tanji, Kenjiro Kohri, Keiichi Tozawa, Mikio Namiki, Hiroyuki Konaka, Hiromi Kumon, Yasutomo Nasu, Yataro Daigo, Hiroki Yoshioka, Wataru Obara, Ryo Takata, Shingo Ashida, Tatsuhiko Tsunoda, Mutsuo Furihata, Kenji Tamura
Supplementary Figure 1 Legend from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3baf427d8fb70d8d637826d443246611
https://doi.org/10.1158/0008-5472.22368561
https://doi.org/10.1158/0008-5472.22368561
Autor:
Hidewaki Nakagawa, Yusuke Nakamura, Taro Shuin, Tomoaki Fujioka, Tsuneharu Miki, Yoichi Mizutani, Hideyuki Akaza, Toru Shimazui, Masayoshi Yokoyama, Nozomu Tanji, Kenjiro Kohri, Keiichi Tozawa, Mikio Namiki, Hiroyuki Konaka, Hiromi Kumon, Yasutomo Nasu, Yataro Daigo, Hiroki Yoshioka, Wataru Obara, Ryo Takata, Shingo Ashida, Tatsuhiko Tsunoda, Mutsuo Furihata, Kenji Tamura
One of the most critical issues in prostate cancer clinic is emerging hormone-refractory prostate cancers (HRPCs) and their management. Prostate cancer is usually androgen dependent and responds well to androgen ablation therapy. However, at a certai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32aca7a07eb167a29aabea731ce38e92
https://doi.org/10.1158/0008-5472.c.6495999
https://doi.org/10.1158/0008-5472.c.6495999
Autor:
Hidewaki Nakagawa, Yusuke Nakamura, Taro Shuin, Tomoaki Fujioka, Tsuneharu Miki, Yoichi Mizutani, Hideyuki Akaza, Toru Shimazui, Masayoshi Yokoyama, Nozomu Tanji, Kenjiro Kohri, Keiichi Tozawa, Mikio Namiki, Hiroyuki Konaka, Hiromi Kumon, Yasutomo Nasu, Yataro Daigo, Hiroki Yoshioka, Wataru Obara, Ryo Takata, Shingo Ashida, Tatsuhiko Tsunoda, Mutsuo Furihata, Kenji Tamura
Supplementary Figure 1 from Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695ef2354d75a3c5fa699fe01c3ceb28
https://doi.org/10.1158/0008-5472.22368558
https://doi.org/10.1158/0008-5472.22368558
Autor:
Takeshi Hirata, Seung Chol Park, Michelle T. Muldong, Christina N. Wu, Tomonori Yamaguchi, Amy Strasner, Omer Raheem, Hiromi Kumon, Robert L. Sah, Nicholas A. Cacalano, Catriona H.M. Jamieson, Christopher J. Kane, Koichi Masuda, Anna A. Kulidjian, Christina A.M. Jamieson
Publikováno v:
Asian Journal of Urology, Vol 3, Iss 4, Pp 229-239 (2016)
Objective: Bone metastasis occurs in up to 90% of men with advanced prostate cancer and leads to fractures, severe pain and therapy-resistance. Bone metastases induce a spectrum of types of bone lesions which can respond differently to therapy even w
Externí odkaz:
https://doaj.org/article/d195ba8d9f63409e98fe8b47e7c19eb8
Publikováno v:
Anticancer Research. 41:4837-4855
Background/aim The adenovirus vector- carrying reduced expression in immortalized cell (REIC) gene (Ad-REIC) increases endoplasmic reticulum stress chaperone GRP78/BiP expression and induces the JNK-mediated apoptotic pathway. We aimed to determine w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::015a9fdf4ef87c5ced0fbe729afd7082
https://doi.org/10.21873/anticanres.15298
https://doi.org/10.21873/anticanres.15298
Autor:
Hiromi Kumon, Katsumi Sasaki, Yuichi Ariyoshi, Takuya Sadahira, Shin Ebara, Takao Hiraki, Susumu Kanazawa, Hiroyuki Yanai, Masami Watanabe, Yasutomo Nasu
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2015, Iss 9, Pp 31-38 (2015)
Externí odkaz:
https://doaj.org/article/67539e179e284204be58cb9e9111e50e